OpenAlex
PricingAboutJobs
Log inGet started
Work

Safety and activity of DCR-MYC, a first-in-class Dicer-substrate small interfering RNA (DsiRNA) targeting MYC, in a phase I study in patients with advanced solid tumors.

HTML

Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2015.33.15_suppl.11006
Authors: Anthony W. Tolcher, Kyriakos P. Papadopoulos, Amita Patnaik, Drew Warren Rasco, Dorothy Martinez, Debra L Wood, Barbara Fielman, Manish Sharma, Linda A. Janisch, Bob D Brown, Pankaj Bhargava, Mark J. Ratain
Institutions: South Texas Accelerated Research Therapeutics, Raleigh Neurology Associates, Vermont Technical College, Dicerna Pharmaceuticals (United States), University of Chicago
Language: English

Topic: RNA Interference and Gene Delivery
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: c-Myc, RNA interference, siRNA therapeutics, advanced solid tumors, safety, anticancer activity, siRNA delivery, siRNA degradation, siRNA toxicity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2502048764
Cites:
Cited by: 122
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security